Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT05730582

Increasing Uptake of EHR-enabled Population Health Outreach Strategies to Improve Diabetes Screening

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
500,000 (estimated)
Sponsor
University of Texas Southwestern Medical Center · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The study team's central hypothesis is that the Parkland Diabetes Detection Program (PDDP) screening invitations targeted by race/ethnicity with culturally concordant messaging and tailored by glycemic risk (known PDM vs. unknown glycemic state) plus phone-based navigation of non-responders will be more effective at closing screening gaps than PDDP generic screening invitations and usual care, opportunistic screening alone.

Detailed description

The research team will conduct a pragmatic, split cluster randomized controlled trial (clinic=cluster; patient randomization) in 12 community-based primary care clinics in an integrated safety net health system serving a high-risk, racially/ethnically diverse population.

Conditions

Interventions

TypeNameDescription
BEHAVIORALParkland Diabetes Detection Program (PDDP) Screening InvitationThe PDDP is designed to supplement and close screening gaps that persist despite opportunistic screening. Program staff order diabetes screening tests for randomized patients, then mail screening invitation letters to inform patients that they are at risk for diabetes. The letter informs them that a screening test has been ordered, and requests that they complete testing at their clinic lab. Patients who were mailed the letter but have not completed screening after 30 days are tracked and are send a second "reminder" invitation. Patients randomized to the targeted-tailored intervention study arm receive an additional phone call after 30 days.

Timeline

Start date
2024-03-05
Primary completion
2026-12-01
Completion
2028-12-30
First posted
2023-02-16
Last updated
2025-04-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05730582. Inclusion in this directory is not an endorsement.